News|Articles|February 12, 2025

What Community Oncologists Should Watch for at ASCO GU 2025

Author(s)Jordyn Sava
Fact checked by: Jason M. Broderick

As the 2025 ASCO Genitourinary Cancers Symposium approaches, several highly anticipated studies are set to shape the future of treatment for prostate, kidney, bladder, and other genitourinary cancers.

As the 2025 ASCO Genitourinary Cancers Symposium (ASCO GU) approaches, several highly anticipated studies are set to shape the future of treatment for prostate, kidney, bladder, and other genitourinary cancers. Here’s a roundup of the key trials to watch out for at the meeting: